Online Database of Chemicals from Around the World

N-(Hydroxymethyl)nicotinamide
[CAS# 3569-99-1]

List of Suppliers
Epochem Co., Ltd. China Inquire  
+86 (21) 6760-1595
6760-1597
seth_wang@epochem.com
QQ chat
Chemical manufacturer since 2006
chemBlink standard supplier since 2005
Simagchem Corporation China Inquire  
+86 13806087780
sale@simagchem.com
Chemical manufacturer since 2002
chemBlink standard supplier since 2008
Shaanxi Xi Yue Pharmaceutical Co., Ltd. China Inquire  
+86 (029) 8823-0456
hcyhsbb@163.com
Chemical manufacturer since 1998
chemBlink standard supplier since 2025
Sarchem Laboratories, Inc. USA Inquire  
+1 (732) 708-1777
sarchem@aol.com
Chemical manufacturer since 1984
Xi'an Huayao Pharm-Chem Institute China Inquire  
+86 (29) 8624-6986
info@huayaochem.com
Chemical manufacturer since 1999
Complete supplier list of N-(Hydroxymethyl)nicotinamide
Identification
Classification API >> Digestive system medication >> Biliary medicine
Name N-(Hydroxymethyl)nicotinamide
Synonyms 3-Pyridinecarboxylic acid N-hydroxymethylamide
Molecular Structure CAS # 3569-99-1, N-(Hydroxymethyl)nicotinamide, 3-Pyridinecarboxylic acid N-hydroxymethylamide
Molecular Formula C7H8N2O2
Molecular Weight 152.15
CAS Registry Number 3569-99-1
EC Number 222-668-4
SMILES C1=CC(=CN=C1)C(=O)NCO
Properties
Density 1.3±0.1 g/cm3 Calc.*
Melting point 152 - 154 ºC (Expl.)
Boiling point 427.7±25.0 ºC 760 mmHg (Calc.)*
Flash point 212.5±23.2 ºC (Calc.)*
Index of refraction 1.569 (Calc.)*
* Calculated using Advanced Chemistry Development (ACD/Labs) Software.
Safety Data
Hazard Symbols symbol   GHS07 Warning    Details
Hazard Statements H315-H319-H335    Details
Precautionary Statements P261-P264-P264+P265-P271-P280-P302+P352-P304+P340-P305+P351+P338-P319-P321-P332+P317-P337+P317-P362+P364-P403+P233-P405-P501    Details
Hazard Classification
up    Details
HazardClassCategory CodeHazard Statement
Skin irritationSkin Irrit.2H315
Eye irritationEye Irrit.2H319
Specific target organ toxicity - single exposureSTOT SE3H335
SDS Available
up Discovory and Applicatios
N-(Hydroxymethyl)nicotinamide is a chemically modified derivative of nicotinamide, in which a hydroxymethyl group (–CH2OH) is attached to the nitrogen atom of the nicotinamide moiety. It retains the core structure of nicotinamide, a form of vitamin B3 (niacin), and belongs to the class of substituted pyridines. This compound exists as a crystalline solid and is moderately soluble in water. Its synthesis involves the formal condensation of nicotinamide with formaldehyde, leading to the formation of an N-hydroxymethyl functional group.

The development of N-(hydroxymethyl)nicotinamide was part of efforts to generate derivatives of nicotinamide with altered pharmacokinetic or functional properties. Nicotinamide itself is a key precursor of the coenzymes NAD+ (nicotinamide adenine dinucleotide) and NADP+ (nicotinamide adenine dinucleotide phosphate), which play central roles in redox reactions, energy metabolism, DNA repair, and cellular signaling. Modification of the nicotinamide structure, such as through N-alkylation or N-hydroxymethylation, has been explored to study structure-activity relationships or to develop compounds with specialized biological behavior.

While N-(hydroxymethyl)nicotinamide is not a widely used pharmaceutical agent, it has been investigated in research contexts for its potential as a biochemical intermediate or modulator of nicotinamide-dependent pathways. Its structural similarity to nicotinamide suggests it may interact with enzymes or transporters related to NAD+ biosynthesis or metabolism, although detailed pharmacological data are limited. The hydroxymethyl group can potentially enhance water solubility or alter the reactivity of the molecule compared to the parent compound.

The compound has been studied as an intermediate in synthetic chemistry and biochemical studies, particularly in the modification of nicotinamide analogs for use in enzyme inhibition or coenzyme mimicry. Its ability to release formaldehyde under certain conditions has also been noted, which may be relevant in the context of stability or reactivity assessments.

In general, the safety, metabolism, and in vivo effects of N-(hydroxymethyl)nicotinamide have not been as thoroughly characterized as those of nicotinamide. However, no widespread toxicological concerns have been associated with its reported uses in experimental systems. Its reactivity and potential to undergo further transformations, such as oxidation or hydrolysis, are of interest in studies involving chemical biology and redox systems.

In summary, N-(hydroxymethyl)nicotinamide is a synthetic derivative of nicotinamide that incorporates a hydroxymethyl substituent on the amide nitrogen. While it has not been widely applied in therapeutic contexts, it serves as a compound of interest in chemical and biochemical research due to its structural relationship to nicotinamide and potential interactions with coenzyme-related pathways.

References

2010. Complexation of cyclodextrins with nicotinamide and N-(hydroxymethyl)nicotinamide in aqueous solution. Russian Journal of General Chemistry, 80(2).
DOI: 10.1134/s1070363210020246

1992. Synthesis of nicotinic acid and hydroxymethylamide by the hydroformylation of 3-cyanopyridine. Pharmaceutical Chemistry Journal, 26(2).
DOI: 10.1007/bf00766464
Market Analysis Reports
List of Reports Available for N-(Hydroxymethyl)nicotinamide
Related Products
2-Hydroxymethylmorpholine  (S)-6-(Hydroxymethyl)morpholin-3-on  6-(Hydroxymethyl)-3-morpholinone  (R)-6-(Hydroxymethyl)morpholin-3-one  5-(Hydroxymethyl)-3-morpholinone  1-[(2R,6S)-6-(Hydroxymethyl)-2-morpholinyl]-5-methyl-2,4(1H,3H)-pyrimidinedione  (2R-cis)-N-[9-[6-(Hydroxymethyl)-2-morpholinyl]-9H-purin-6-yl]benzamide  1-[(2R,6S)-6-(Hydroxymethyl)-2-morpholinyl]-2,4(1H,3H)-pyrimidinedione  1-Hydroxy-N-methyl-2-naphthalenecarboxamide  6-Hydroxy-N-methyl-1-naphthamide  2-(4-Hydroxy-6-methylnicotinamido)-2-(4-hydroxyphenyl)acetic acid  4-Hydroxy-6-methylnicotinic acid  5-Hydroxy-2-methylnicotinic acid  (alphaS,betaR)-beta-Hydroxy-alpha-methyl-4-nitrobenzenepropanal  [R-(R*,R*)]-[1-(Hydroxymethyl)-2-methylbutyl]carbamic acid 1,1-dimethylethyl ester  6-(Hydroxymethyl)-3-methyl-3,4-dihydro-2(1H)-quinazolinone  4-(Hydroxymethyl)-5-methyl-1,3-dioxol-2-one  11beta-Hydroxy-16alpha-methyl-6-methylene-17,20:20,21-bis(methylenedioxy)-pregn-4-en-3-one  (8R)-5-hydroxy-8-methyl-9-[6-[[(1-methylethoxy)carbonyl]amino]-9H-purin-9-yl]-2,4,7-Trioxa-5-phosphanonanoic acid 1-methylethyl ester 5-oxide  5-(Hydroxymethyl)-2',3'-O-(1-methylethylidene)-2-thiouridine